News

Researchers at the University of Chicago found that the TET2 gene affects RNA modifications, influencing how DNA is packaged in cells. TET2 mutations may lead to cancer by disrupting this process, suggesting new targets for therapies.

Researchers from the University Hospital Bonn have reassessed over 10,000 genetic variants linked to hereditary colorectal cancer. Using new classification criteria, they reclassified 41% of uncertain variants as benign.

A new clinical testing pathway could identify cancer-causing BRCA mutations, ensuring patients get the right treatment.

Research analyzing over 700 U.S. counties reveals a correlation between childhood leukemia and radon gas levels, including those below EPA guidelines. The study emphasizes the need for further investigation into environmental cancer risks.

By taking hints from a protein's "twin", researchers have uncovered new drug binding sites.

Researchers have developed a convoy of miniature robots capable of performing endoscopic surgeries. By combining multiple TrainBots with enhanced anti-slip feet, they successfully maneuvered an electrode through a bile duct obstruction.

A new study shows the potential power of imaging paired with radiation to shape treatment for glioblastoma patients in real time.

A study led by researchers from the University of Birmingham found the IOTA ADNEX ultrasound model detected 96% of ovarian cancers in postmenopausal women, outperforming the current standard of care.

A new hand-held scanner can generate highly detailed 3D photoacoustic images in just seconds, potentially transforming cancer and arthritis diagnosis.

A study from UC Irvine reveals that disturbances in the circadian clock can change the gut microbiome and intestinal barrier function, potentially increasing colorectal cancer risk.